Anti-atherosclerotic effect of repaglinide or glimepiride in Japanese type 2 diabetic patients
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000008324
- Lead Sponsor
- Fukuoka university, school of medicine, Department of Endocinology and Diebtes Mellitus
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
type 1 diabetes episode of diabetic ketosis current use of sulfonylure, glinides or insulin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c(NGSP) Cervical IMT serum 8OHdG hsCRP oxidized LD
- Secondary Outcome Measures
Name Time Method